{
    "case_number": "CAC-UDRP-108196",
    "time_of_filling": "2025-12-18 09:41:49",
    "domain_names": [
        "neuropure.net"
    ],
    "case_administrator": "  Iveta Špiclová   (Czech Arbitration Court) (Case admin)",
    "complainant": [
        "Société des Produits Nestlé S.A."
    ],
    "complainant_representative": "Thomsen Trampedach GmbH",
    "respondent": [
        "manpreet singh"
    ],
    "respondent_representative": null,
    "factual_background": "<p>The Complainant, Soci&eacute;t&eacute; des Produits Nestl&eacute; S.A., is a wholly owned subsidiary of Nestl&eacute; S.A., the main operating company in the Nestl&eacute; Group, which was founded by Henri Nestl&eacute; in 1866. The Complainant owns the US national trademark, NEUROPURE.<\/p>\n<p>The Nestl&eacute; Group markets its products in 190 countries. It has about 275 000 employees worldwide and has a physical presence in 80 countries. It offers a broad range of products, including dietary supplements under several brands. Among these brands is Pure Encapsulations, which focuses on hypoallergenic supplements. In 2012, Pure Encapsulations launched the \"Integrative Mental Health Series\", which included the key product NeuroPure. NeuroPure is formulated to support serotonin and dopamine production and has been marketed continuously in the United States since 2012.<\/p>\n<p>The Respondent is located in Mukstar, India. The Respondent registered the disputed domain name on 5 August 2024. The disputed domain name resolves to a website that promotes a neurological supplement that is also branded \"NeuroPure\".<\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p><strong>Complainant<\/strong><\/p>\n<p>The Complainant submits that the disputed domain name is identical to a trademark in which the Complainant has rights. It argues that the Respondent has no rights or legitimate interests in the disputed domain name and states:<\/p>\n<ol style=\"list-style-type: lower-roman;\">\n<li>the Respondent is not commonly known by the disputed domain name;<\/li>\n<li>the disputed domain name is not being used for a bona fide offering of goods or services; and<\/li>\n<li>the disputed domain name is being used to display a website advertising a neurological supplement under the NEUROPURE mark that corresponds with the Complainant's pre-existing NEUROPURE product.<\/li>\n<\/ol>\n<p>The Complainant asserts that its NEUROPURE mark was first used in commerce in 2012.&nbsp; It states that the Respondent registered and has used the disputed domain name in bad faith and that it is being used sell products under the NEUROPURE name in competition with those of the Complainant.&nbsp;<\/p>\n<p>The Complainant also contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n<p><strong>Respondent<\/strong><\/p>\n<p>The Respondent has not filed a Response to the Compliant.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Veronica  Bailey"
    ],
    "date_of_panel_decision": "2026-01-22 00:00:00",
    "informal_english_translation": "<p>The Complainant is the registered owner of the US national trademark, NEUROPURE, registration number 7790279, filed 15 November 2023 and registered 13 May 2025 in international class 5 for nutritional supplements; nutritional and dietary supplements; vitamin preparations; and mineral food supplements.<\/p>",
    "decision_domains": {
        "neuropure.net": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}